Skip to main content

BeiGene opens European headquarters in Basel

| News

BeiGene opens European headquarters in Basel

19.05.2022

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build on European growth out of Basel and its office will initially include 150 employees.

At the opening event: Christof Klöpper, CEO of Basel Area Business & Innovation, talks while John V. Oyler (seated far right), CEO of BeiGene, listens attentively (img: Annelise Michel)

Basel is joining Cambridge, Massachusetts, and Beijing, China, as a location of one of the main regional offices of BeiGene. According to a press release, the biotech’s European organization currently includes more than 270 employees. The Basel office will become a hub for BeiGene’s operations in Europe and initially employ 150 members of staff.

“The skilled talent network in Basel will support our future growth,” said John V. Oyler, Co-Founder, Chairman and CEO at BeiGene. And this is “just the beginning” of growth plans in Europe.

BeiGene is a global, commercial-stage, research-based biotechnology company focused on molecularly-targeted and immuno-oncology cancer therapeutics. Its internal pipeline reportedly consists of 40 novel oral small molecules and monoclonal antibodies for cancer.

“Basel is the biotech hub of continental Europe“

At the opening event of BeiGene Switzerland GmbH, Deborah Strub, Member of the Executive Board and Head of the Cluster & Initiatives Department at the Chamber of Commerce of the two Basel cantons, said “BeiGene’s presence also represents a great opportunity for the Swiss and particularly the Basel economy”. Gerwin Winter, Head of Europe at BeiGene, commented “our new European headquarters in Basel will further strengthen our position and will be a catalyst for changing the lives of European patients.”

Christof Klöpper, CEO of Basel Area Business & Innovation, also welcomes the opening of the new offices. In an article in the Basler Zeitung newspaper he is quoted as saying “Basel is the biotech hub of continental Europe. In recent years we have worked hard to promote this message – to the USA and also China“.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.